Alumis ALMS
NASDAQ ALMS
$7.90 +0.13 (+1.67%)
At close: Sep 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Cash from Operations (2023 - 2025)

Alumis' (ALMS) quarterly Cash from Operations came in at -$71.9 million in Q4 2025, up 3.85% year-over-year from -$69.2 million in Q4 2024, and up 35.17% quarter-over-quarter from -$110.9 million in Q3 2025.

Analysis

Alumis (ALMS) Cash from Operations (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Cash from Operations for 3 consecutive years, with -$71.9 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Cash from Operations rose 3.85% year-over-year to -$71.9 million in Q4 2025; TTM through Dec 2025 was -$369.5 million, a 44.85% decrease from a year earlier, with the FY2025 full-year figure at -$369.5 million, down 44.85% from the prior year.
  • Cash from Operations was -$71.9 million for Q4 2025 at Alumis, up from -$110.9 million in the prior quarter.
  • Over five years, Cash from Operations peaked at -$33.2 million in Q3 2023 and troughed at -$110.9 million in Q3 2025.
  • A 3-year average of -$69.2 million and a median of -$73.3 million in 2024 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations plunged 151.96% in 2024 and grew 3.85% in 2025, its largest moves.
  • Over 3 years, Cash from Operations stood at -$33.8 million in 2023, then slumped by 121.58% to -$74.8 million in 2024, then climbed by 3.85% to -$71.9 million in 2025.
  • The last three Cash from Operations figures came in at -$71.9 million (Q4 2025), -$110.9 million (Q3 2025), and -$106.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 813.00 Mn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -526.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -270.50 Mn
10 Alumis 966.94 Mn 464.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -71.91 Mn
Sep 30, 2025 -110.91 Mn
Jun 30, 2025 -106.31 Mn
Mar 31, 2025 -80.40 Mn
Dec 31, 2024 -74.79 Mn
Sep 30, 2024 -83.77 Mn
Jun 30, 2024 -52.25 Mn
Mar 31, 2024 -44.30 Mn
Dec 31, 2023 -33.75 Mn
Sep 30, 2023 -33.25 Mn
API Access

Alumis Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ALMS&period=max&api_key=YOUR_API_KEY